Insights

Domestic expansion DEMECAN is expanding its cultivation operations in Saxony and Western Europe, signaling increasing domestic production capacity and potential for higher local supply, enabling upsell opportunities to German medical providers and regional distributors.

Market leadership As the German market leader for medicinal cannabis with a focus on quality and sustainability, DEMECAN presents a compelling partner profile for hospitals, clinics, and pharmacies seeking reliable, compliant supply of cannabis products.

Financial health With revenue in the multi‑million range and a notable Series A history, DEMECAN has demonstrated financing capability and growth ambition, indicating potential for scalable supply agreements and expanded product lines.

End‑to‑end solutions DEMECAN offers sustainable cultivation and wholesale solutions for the German medical cannabis industry, suggesting opportunities for value‑added services such as compliant logistics, quality assurance programs, and patient‑focused product bundles.

Tech‑enabled ops Adoption of enterprise tools like Microsoft Dynamics 365 Business Central and Wrike indicates a modernization of operations; this can support scalable procurement, contract management, and streamlined onboarding for new distributors and healthcare partners.

DEMECAN Tech Stack

DEMECAN uses 8 technology products and services including html5media, Tableau, Google Workspace, and more. Explore DEMECAN's tech stack below.

  • html5media
    Audio, Video, Graphics
  • Tableau
    Business Intelligence
  • Google Workspace
    Email
  • Microsoft Dynamics
    Enterprise Resource Planning
  • styled-components
    Javascript Frameworks
  • PHP
    Programming Languages
  • Google
    Search Engines
  • Facebook
    Widgets

DEMECAN's Email Address Formats

DEMECAN uses at least 1 format(s):
DEMECAN Email FormatsExamplePercentage
First.Last@demecan.deJohn.Doe@demecan.de
97%
Last.First@demecan.deDoe.John@demecan.de
2%
First.Middle@demecan.deJohn.Michael@demecan.de
1%

Frequently Asked Questions

What is DEMECAN's official website and social media links?

Minus sign iconPlus sign icon
DEMECAN's official website is demecan.de and has social profiles on LinkedIn.

What is DEMECAN's NAICS code?

Minus sign iconPlus sign icon
DEMECAN's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does DEMECAN have currently?

Minus sign iconPlus sign icon
As of July 2026, DEMECAN has approximately 81 employees across 1 continents, including Europe. Key team members include Cfo - Power Of Attorney (prokurist): R. F.Chief Digital Officer (cdo): S. M.Head Of Supply Chain Management: A. H.. Explore DEMECAN's employee directory with LeadIQ.

What industry does DEMECAN belong to?

Minus sign iconPlus sign icon
DEMECAN operates in the Pharmaceutical Manufacturing industry.

What technology does DEMECAN use?

Minus sign iconPlus sign icon
DEMECAN's tech stack includes html5mediaTableauGoogle WorkspaceMicrosoft Dynamicsstyled-componentsPHPGoogleFacebook.

What is DEMECAN's email format?

Minus sign iconPlus sign icon
DEMECAN's email format typically follows the pattern of First.Last@demecan.de. Find more DEMECAN email formats with LeadIQ.

How much funding has DEMECAN raised to date?

Minus sign iconPlus sign icon
As of July 2026, DEMECAN has raised $24M in funding. The last funding round occurred on Aug 07, 2024.

When was DEMECAN founded?

Minus sign iconPlus sign icon
DEMECAN was founded in 2017.
DEMECAN logo

DEMECAN

Pharmaceutical ManufacturingSaxony, Germany51-200 Employees

DEMECAN is a mid-sized pharmaceutical manufacturer based in Thiendorf, Saxony, Germany. It holds the position of German market leader for medicinal cannabis and focuses on sustainable cultivation and wholesale. The company provides comprehensive solutions for Germany's medical cannabis sector, prioritizing quality, innovation, and service while aiming to improve access to high-quality medicinal cannabis for patients.

In 2026, DEMECAN announced expansions of its offices across Germany and Western Europe and an expansion of cultivation operations at its Ebersbach site in Saxony to bolster domestic production capacity. This growth reflects an effort to strengthen domestic supply within a market that remains reliant on imports.

Section iconCompany Overview

Website
demecan.de
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2017
Employees
51-200

Section iconFunding & Financials

  • $24M

    DEMECAN has raised a total of $24M of funding over 6 rounds. Their latest funding round was raised on Aug 07, 2024as a series_unknown.

  • $10M$25M

    DEMECAN's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $24M

    DEMECAN has raised a total of $24M of funding over 6 rounds. Their latest funding round was raised on Aug 07, 2024as a series_unknown.

  • $10M$25M

    DEMECAN's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.